Immune Thrombocytopenia (ITP): Relapse Versus de novo After COVID-19 Vaccination

Clin Appl Thromb Hemost. 2022 Jan-Dec:28:10760296211073920. doi: 10.1177/10760296211073920.
No abstract available

Keywords: COVID-19 vaccination; coagulation; immune thrombocytopenia.

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Adult
  • BNT162 Vaccine / administration & dosage
  • BNT162 Vaccine / adverse effects*
  • BNT162 Vaccine / immunology
  • ChAdOx1 nCoV-19 / administration & dosage
  • ChAdOx1 nCoV-19 / adverse effects*
  • ChAdOx1 nCoV-19 / immunology
  • Female
  • Hospitalization
  • Humans
  • Male
  • Middle Aged
  • Purpura, Thrombocytopenic, Idiopathic / blood
  • Purpura, Thrombocytopenic, Idiopathic / chemically induced*
  • Purpura, Thrombocytopenic, Idiopathic / immunology
  • Purpura, Thrombocytopenic, Idiopathic / therapy
  • Recurrence
  • Time Factors
  • Treatment Outcome
  • Vaccination / adverse effects*
  • Young Adult

Substances

  • ChAdOx1 nCoV-19
  • BNT162 Vaccine